These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2483965)

  • 1. [The minimal fragment of substance P preserving the properties of this peptide].
    Golubovich VP; Egorova SV; Osipovich IN; Lazakovich EM; Kirnarskiĭ LI
    Dokl Akad Nauk SSSR; 1989; 309(4):1000-1. PubMed ID: 2483965
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
    Bahouth SW; Stewart JM; Musacchio JM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):116-23. PubMed ID: 6205134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent action of N-methylated analogs of substance P on rat parotid slices.
    Laufer R; Chorev M; Gilon C; Friedman ZY; Wormser U; Selinger Z
    FEBS Lett; 1981 Jan; 123(2):291-4. PubMed ID: 6164572
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
    Kachur JF; Miller RJ; Field M; Rivier J
    J Pharmacol Exp Ther; 1982 Mar; 220(3):456-63. PubMed ID: 6174727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of substance P and its fragments on the activity of angiotensin converting enzyme].
    Siems WE; Komissarova NV; Gomazkov OA; Heder G
    Patol Fiziol Eksp Ter; 1984; (3):79-81. PubMed ID: 6206462
    [No Abstract]   [Full Text] [Related]  

  • 6. The 'septide-sensitive' tachykinin receptor: still an enigma.
    Glowinski J
    Trends Pharmacol Sci; 1995 Nov; 16(11):365-7. PubMed ID: 8578604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of substance P and its fragments: analgesic properties, effect on behavior and monoaminergic processes].
    Klusha VE; Abissova NA; Mutsenietse RK; Svirskis ShV; Binert M
    Biull Eksp Biol Med; 1981 Dec; 92(12):692-4. PubMed ID: 6173081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences in activity between substance P and substance P-heptapeptide as studied on the phenomenon of "gut dependence" in rats (author's transl)].
    Nieber K; Oehme P
    Pharmazie; 1982 May; 37(5):368-9. PubMed ID: 6180443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of morphine, methadone and methadone isomers on some effects of smooth muscle stimulants.
    Antopol W; Chryssanthou C
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):121-40. PubMed ID: 5524312
    [No Abstract]   [Full Text] [Related]  

  • 10. A substance P antagonist not containing D-tryptophan.
    Escher E; D'Orléans-Juste P; Dion S; Drapeau G; Mizrahi J; Regoli D
    Eur J Pharmacol; 1984 Oct; 105(3-4):375-7. PubMed ID: 6210204
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 'casoparan', a peptide isolated from casein hydrolysates with mastoparan-like properties.
    Lebrun I; Cavallaro V; Juliano L; Juliano MA; de Sousa e Silva MC
    Mediators Inflamm; 2004 Aug; 13(4):263-8. PubMed ID: 15545057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality.
    Fransson R; Botros M; Nyberg F; Lindeberg G; Sandström A; Hallberg M
    Neuropeptides; 2008 Feb; 42(1):31-7. PubMed ID: 18093649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of substance P antagonists: [D-Pro4, D-Trp7,9,Nle11]-substance P(4-11).
    Köller G; Bienert M; Niedrich H; Bergmann J; Mezö I; Oehme P
    Pharmazie; 1984 Jan; 39(1):65-7. PubMed ID: 6201929
    [No Abstract]   [Full Text] [Related]  

  • 14. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.
    Zhou Q; Kindlundh AM; Hallberg M; Nyberg F
    Peptides; 2004 Nov; 25(11):1951-7. PubMed ID: 15501527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P and analogues: biological activity and degradation.
    Teichberg VI; Blumberg S
    Prog Biochem Pharmacol; 1980; 16():84-94. PubMed ID: 6160595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to the elucidation of self-regulatory mechanism of substance P action. I. Synthesis and biological properties of pentapeptides related both to the substance P C-terminal fragment and enkephalins.
    Lipkowski AW; Osipiak B; Członkowski A; Gumułka WS
    Pol J Pharmacol Pharm; 1982; 34(1-3):63-8. PubMed ID: 6188134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity and enzymic degradation of substance P analogs: implications for studies of the substance P receptor.
    Blumberg S; Teichberg VI
    Biochem Biophys Res Commun; 1979 Sep; 90(1):347-54. PubMed ID: 496986
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of substance P analogs substituted at the Gly9 and Gln6 positions.
    Blumberg S; Teichberg VI
    Biochem Biophys Res Commun; 1981 Mar; 99(2):752-8. PubMed ID: 6165365
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological properties of the [5-(N5-dimethyl)-glutamine]-analogue of the C-terminal heptapeptide of substance P: active-site studies.
    Pinas N; Poulos CP; Theodoropoulos D
    FEBS Lett; 1979 Dec; 108(1):45-6. PubMed ID: 520562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.